2 assets in Coronary Microvascular Disorder

Therapeutic assets addressing Coronary Microvascular Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Tirzepatide Coronary Microvascular Disorder	Tina Vilsbøll	P4	BB (65)
Vericiguat Coronary Microvascular Disorder	Johns Hopkins University	P2	B (57)